Prognostic Value of Stem Cell Related Markers

Withdrawn

• Conditions: Breast Cancer

• Registration Number: NCT01265225
• Lead Sponsor: The Baruch Padeh Medical Center, Poriya

Brief Summary

The goal of the investigators study is to identify a prognostic marker that will evaluate the probability of recurrence in patients with stage 0-II breast cancer following surgery to remove the tumor.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2010-12-21
• Study First Submitted QC: 2010-12-22
• Study First Posted: 2010-12-23
• Study Start: 2011-02
• Primary Completion: 2013-02
• Study Completion: 2013-04
• Status Verified: 2013-12
• Last Update Submitted: 2013-12-22
• Last Update Posted: 2013-12-24

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

• Ductal Carcinoma in Situ
• DCIS + Microinvasion stages 1 or 11 without positive lymph nodes

Exclusion Criteria

• tumor specimen with higher than grade II
• BRACA 1 or BRACA 2 mutation
• Neoadjuvant chemotherapy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Baruch PMC; 🇮🇱 Poriya, Lower galilee, Israel